The attempt at tailor-made obesity treatments; Biden requests $20B to bolster public health

Some physicians test to determine a "unique obesity phenotype" and custom-tailor treatments.

March 9, 2023 Check out STAT+

Sponsored By

Katy Lemay for STAT STAT+ | 'Emotional hunger' vs. 'hungry gut': The attempt to subtype obesity and tailor treatments Some doctors test for a "unique obesity phenotype" and tailor treatments. But the jury's out on "precision" weight loss interventions. By Julia Belluz Biden administration requests $20 billion cash infusion to bolster public health The Biden administration's CDC budget request overall increased from $11 billion last year to $13.1 billion this year. By Rachel Cohrs With an $11 billion price tag, the White House pitches a plan to end hepatitis C The Biden administration is calling on Congress to fund a more than $11 billion program to eliminate hepatitis C in the United States. By Nicholas Florko BRENDAN SMIALOWSKI/AFP via Getty Images 'Truth is losing the battle': FDA commissioner on grappling with a wave of health misinformation STAT spoke with FDA Commissioner Robert Califf about how the agency could rein in rampant health misinformation on drugs and vaccines. By Ben Brody STAT+ | Mice with two fathers and base-edited baby monkeys highlight potential — and limitations — of hereditable gene editing New research on mice points to the eventual possibility of male-male couples having children who are genetically related to both of them. By Megan Molteni Pfizer CEO Albert Bourla maxed out campaign contributions to Dr. Oz ahead of midterm elections Pfizer CEO Albert Bourla made the maximum possible campaign contribution to Mehmet Oz ahead of his failed bid for Senate in Pennsylvania. By Rachel Cohrs Hyacinth Empinado/STAT Watch: The troubled history of BMI, the body mass index Despite the ubiquity of the body mass index, or BMI, in medicine, many argue that it is a flawed tool, with a strange history. By Hyacinth Empinado STAT+ | Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment The bill comes after Lilly cut list prices for its most commonly prescribed insulin by 70% and plans other steps so insulin is more affordable By Ed Silverman Listen: Robert Califf on how drugs get approved, plus the nascent revolution in obesity FDA Commissioner Robert Califf joins the podcast this week to discuss his first year on the job and the future of drug approvals. By Damian Garde and Meg Tirrell and Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser